Gary W. Pace, an insider at Cardiff Oncology, purchased 290,000 shares (CRDF) at $2.45 each on August 1, totaling an investment of $710,500. Following this purchase, Cardiff Oncology’s stock rose approximately 14.6%.
On the same day, CEO Michael R. Dury of Merchants Bancorp invested $504,936 in 16,000 shares at $31.56 each. Dury has made a total investment of $566,155 in Merchants Bancorp over the past year, with an average purchase price of $34.51 per share. Currently, shares are trading as low as $28.75, which is 8.9% below Dury’s recent purchase price.
